Other languages Biohit Oyj

Equities

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
2.01 ^EUR	+0.50%		+4.69%	+6.63%

Apr. 15	Faron Pharmaceuticals reappoints former finance chief on interim basis	AN
Feb. 14	Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Faron Pharmaceuticals reappoints former finance chief on interim basis	Apr. 15
Bolsa de Madrid: FOMOOOOOO	Feb. 15
FOMOOOOOO	Feb. 15
Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 14
Biohit Names New Chief Commercial Officer	Nov. 22
Biohit Oyj Provides Earnings Guidance for the Period from 2024 to 2028	Nov. 22
Biohit Oyj Announces Changes in the Management Group	Nov. 22
Biohit Revises Earnings Guidance for 2023	23-08-09
Biohit Oyj Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-09
Biohit Oyj Elects Vesa Silaskivi as Chairman of the Board of Directors	23-06-15
Biohit Oyj Approves Election of Vesa Silaskivi as Members of Board of Directors	23-06-14
Biohit Oyj Provides Earnings Guidance for the Year 2023	23-02-15
Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-15
Biohit Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-15
Biohit Oyj Announces Executive Changes	22-12-15
Biohit Appoints New CFO	22-09-06
Biohit Oyj Appoints Jussi Sorvo as Member of the Management, Effective on September 7, 2022	22-09-06
Finnish Biotech Biohit Appoints CFO as CEO	22-09-02
Biohit Oyj Announces Executive Changes	22-09-02
Biohit Oyj Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-10

No results for this search